Regulation of aromatase expression: Potential therapeutic insight into breast cancer treatment

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Estrogen signaling is crucial in hormone-dependent breast cancers, a majority of diagnoses.
• Aromatase, the enzyme synthesizing estrogen, is frequently dysregulated in breast cancer.
• Aromatase inhibitors (AIs) are standard treatment, but acquired resistance is a major clinical hurdle.

Purpose of the Study:

• To review advances in aromatase regulation (transcriptional and post-translational).
• To discuss resistance mechanisms to current aromatase inhibitors.
• To explore novel combination therapies targeting tumor signaling pathways.

Main Methods:

• Literature review of historical and recent research on aromatase.
• Analysis of transcriptional and post-translational regulation mechanisms.
• Overview of current preclinical and clinical drug combination studies.

Main Results:

• Aromatase activity is tightly regulated at multiple levels.
• Acquired resistance to AIs poses a significant challenge in breast cancer therapy.
• Various drug combinations show promise in preclinical and clinical settings.

Conclusions:

• Understanding aromatase regulation is key to overcoming treatment resistance.
• Novel therapeutic strategies involving drug combinations are under development.
• Targeting tumor-promoting pathways alongside aromatase inhibition may improve patient outcomes.